Closer to Autograft Than Ever Before

OSTEOAMP provides essential growth factors supporting bone formation

Clinical Publications

Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: or radiographic and economic analysis

Download Clinical Study ›

Clinical Evaluation of Allogeneic Growth Factor in Cervical Spine Fusion

Download Clinical Study ›

Clinical Validation of Allogeneic Morphogenetic Protein: Donor Intervariability: Terminal irradiation and Age of Product is not Clinically Relevant

Download Clinical Study ›

Request More Information

To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.

Instructions for Use:
OSTEOAMP – DCI Doner Services Tissue Bank
OSTEOAMP – Lifelink Tissue Bank
OSTEOAMP – Pinnacle Transplant Technologies

Material Management Packet:
OSTEOAMP Material Management Packet

First Name*

Last Name*

Email*

Phone Number*

Company*

Job Title*

Your Question or Comment*

Subject of Inquiry*

*Fields with asterisks are mandatory

  1. Bioventus Surgical. Tidwell JL, Seaman SA, Vanderploeg EJ, Tom S. In vitro and in vivo characterization of OSTEOAMP allogeneic morphogenetic proteins. Data on file, Bioventus white paper; 2017.

  2. Roh JS, Yeung CA, Field JS, McClellan RT. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. J Orthop Surg Res. 2013;8:49. doi:10.1186/1749-799X-8-49.

  3. Field J, Yeung C, Roh J. Clinical evaluation of allogeneic growth factor in cervical spine fusion. J Spine 2014;3(158) doi:10.4172/2165-7939.1000158.